secwatch.observer — SEC 8-K summary
======================================

Issuer:     Centessa Pharmaceuticals plc (CNTA)
CIK:        0001847903
Form:       8-K
Filed at:   2025-06-20T23:59:59+00:00
Accession:  0001847903-25-000093
Event type: other_material
Sentiment:  neutral
Materiality: 0.10
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Centessa shareholders approve all proposals at 2025 AGM, including director re-elections
--------------------------------------------------------------------------------

- Re-elected Arjun Goyal with 116.9M votes for, 463,793 against; Samarth Kulkarni with 97.7M for, 19.6M against.
- Approved KPMG LLP as UK statutory auditors and KPMG LLP (Delaware) as independent auditor for FY2025.
- Adopted UK statutory accounts for FY2024; no dividend recommended.
- Authorized directors to allot shares up to £133,184 nominal value under Companies Act.
- Special resolution passed to empower board to allot equity for cash without pre-emption rights.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1847903/000184790325000093/0001847903-25-000093-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1847903/000184790325000093/cnta-20250620.htm
  HTML page:      https://secwatch.observer/filing/0001847903-25-000093

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer